Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Advanced Cell Technology's Studies to Support Phase I Multicenter Trial of Patients with Stargardt's Macular Dystrophy Demonstrate Excellent Safety Profile
Advanced Cell Technology's Studies to Support Phase I Multicenter Trial of Patients with Stargardt's Macular Dystrophy Demonstrate Excellent Safety Profile
Advanced Cell Technology's Studies to Support Phase I Multicenter Trial of Patients with Stargardt's Macular Dystrophy Demonstrate Excellent Safety Profile
Submitted by
admin
on April 24, 2010 - 12:58pm
Source:
Yahoo/BusinessWire
News Tags:
Advanced Cell Technologies
stem cells
Retinal Pigment Epithelium
macular dystrophy
Headline:
Advanced Cell Technology's Studies to Support Phase I Multicenter Trial of Patients with Stargardt's Macular Dystrophy Demonstrate Excellent Safety Profile
Do Not Allow Advertisers to Use My Personal information
